Use of an IBAT inhibitor for the treatment of prophylaxis of constipation

Details for Australian Patent Application No. 2004228731 (hide)

Owner AstraZeneca AB

Inventors Abrahamsson, Hasse Roland; Gillberg, Per-Goran

Agent Davies Collison Cave

Pub. Number AU-B-2004228731

PCT Pub. Number WO2004/089350

Priority 0307918.3 05.04.03 GB

Filing date 1 April 2004

Wipo publication date 21 October 2004

Acceptance publication date 28 February 2008

International Classifications

A61K 31/00 (2006.01)

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61P 1/10 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/089350 Priority application(s): WO2004/089350

28 February 2008 Application Accepted

  Published as AU-B-2004228731

5 June 2008 Assignment before Grant

  AstraZeneca AB The application has been assigned to Albireo AB Assignments before Grant, Section 113

26 June 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004228745-Method of obtaining galliun-68 and use thereof and device for carrying out saif method

2004228718-Intraocular lens and injector for the same